Objective: To describe a registry set up to monitor children treated with etanercept in Germany
and Austria. Methods: Giannini’s criteria, duration of morning stiffness, number of swollen, …

Background Tofacitinib is an oral Janus kinase inhibitor. This trial assessed the efficacy and
safety of tofacitinib versus placebo in patients with polyarticular course juvenile idiopathic …

Objective To describe clinical outcomes of juvenile idiopathic arthritis (JIA) in a prospective
inception cohort of children managed with contemporary treatments. Methods Children newly …

Objective Phagocytes are extensively involved in the synovial inflammation associated with
chronic arthritis. The aim of our study was to determine neutrophil activation in juvenile …

BACKGROUND Undifferentiated systemic autoinflammatory diseases (USAIDs) present
diagnostic and therapeutic challenges. Chronic interferon (IFN) signaling and cytokine …

In an effort to find naturally occurring substances that reduce cholesterol by inhibiting 3-hydroxy-3-methylglutaryl-coenzyme
A reductase (HMGCR), statins were first discovered by Endo …

Objective To use consensus methods and the considerable expertise contained within the
Childhood Arthritis and Rheumatology Research Alliance (CARRA) organization to extend …

Objective To investigate aspects of juvenile dermatomyositis (DM), including disease
characteristics and treatment, through a national multicenter registry. Methods Subjects meeting …

Objective To describe probabilities and characteristics of disease flares in children with juvenile
idiopathic arthritis (JIA) and to identify clinical features associated with an increased risk …

… Schmeling has received honoraria for advisory board service from Roche, AbbVie, and Pfizer
… E-mail: heinrike.schmeling@albertahealthservices.ca. Submitted for publication November …